Drug Type CAR-T |
Synonyms Man9xPS CAR T cell |
Action inhibitors |
Mechanism MAN1A1 inhibitors(mannosidase alpha class 1A member 1 inhibitors), Phosphatidylserine inhibitors(Phosphatidylserine inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | United States | 27 Apr 2025 | |
| Liver Cancer | Preclinical | United States | 27 Apr 2025 | |
| Lung Cancer | Preclinical | United States | 27 Apr 2025 | |
| Pancreatic Cancer | Preclinical | United States | 27 Apr 2025 |





